Display Settings:

Format

Send to:

Choose Destination

    Diabetes. 2004 Feb;53(2):384-92.

    Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.

    Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, Bonifacio E, Ziegler AG.

    Diabetes Research Institute and 3rd Medical Department, Hospital München-Schwabing, Munich, Germany.

    Erratum in:

    • Diabetes. 2004 Apr;53(4):1175-6.

    Family history of type 1 diabetes and autoantibodies to the islet antigens insulin (IAA), glutamate decarboxylase (GADA), and the protein tyrosine phosphatase-like protein IA-2 (IA-2A) are strong predictors of type 1 diabetes, but the rate of progression to diabetes in multiple islet autoantibody-positive relatives varies widely. We asked whether detailed characterization of islet autoantibodies that included determination of titer, epitope specificity, and IgG subclass would improve diabetes prediction in a large cohort of autoantibody-positive relatives. The study shows a strong association between risk and high titer, broad antibody responses to IA-2 and insulin. The highest risks were associated with high-titer IA-2A and IAA, IgG2, IgG3, and/or IgG4 subclass of IA-2A and IAA, and antibodies to the IA-2-related molecule IA-2beta. Using models based on these antibody characteristics, autoantibody-positive relatives can be classified into groups with risks of diabetes ranging from 7 to 89% within 5 years.

    PMID: 14747289 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read